Strategic Advocates’s Hormel Foods HRL Stock Holding History

Strategic Advocates’s Portfolio HRL Stock Details HRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4	Closed	-$96	–	419
2025 Q4	$96	Hold	4	–	–	﹤0.01%	597
2025 Q3	$99	Buy	+4	New	+$111	﹤0.01%	579

Other funds holding HRL

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Strategic Advocates's HRL Position: Q1 2026 in Review

Strategic Advocates sold out of Hormel Foods (HRL) in Q1 2026, closing a stake of 4 shares — an estimated $96 sold.

Strategic Advocates first reported a position in HRL in Q3 2025 and held it in 2 quarters. The position peaked at $99 in Q3 2025. 632 funds tracked by Wall St. Rank hold HRL as of Q1 2026.

Strategic Advocates reported no remaining Hormel Foods position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 4 Hormel Foods shares in Q1 2026, an estimated $96.
Strategic Advocates first reported a position in Hormel Foods in Q3 2025 and held it in 2 quarters.
Strategic Advocates's Hormel Foods position peaked at $99 in Q3 2025.
632 funds tracked by Wall St. Rank held Hormel Foods as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.